塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/25 | 6,875 | 6,900 | 6,845 | 6,880 | +9 | +0.1% | 831,400 |
2022/08/24 | 6,855 | 6,882 | 6,826 | 6,871 | -18 | -0.3% | 894,900 |
2022/08/23 | 6,921 | 6,929 | 6,845 | 6,889 | -99 | -1.4% | 1,303,800 |
2022/08/22 | 6,909 | 6,988 | 6,891 | 6,988 | +88 | +1.3% | 1,155,300 |
2022/08/19 | 6,975 | 6,998 | 6,900 | 6,900 | -100 | -1.4% | 1,271,000 |
2022/08/18 | 6,981 | 7,004 | 6,917 | 7,000 | +3 | ±0% | 963,900 |
2022/08/17 | 7,009 | 7,009 | 6,952 | 6,997 | +2 | ±0% | 1,274,300 |
2022/08/16 | 6,949 | 7,003 | 6,904 | 6,995 | +16 | +0.2% | 1,126,400 |
2022/08/15 | 6,940 | 6,989 | 6,921 | 6,979 | +63 | +0.9% | 1,224,900 |
2022/08/12 | 6,949 | 6,960 | 6,867 | 6,916 | +54 | +0.8% | 1,695,300 |
2022/08/10 | 6,815 | 6,868 | 6,759 | 6,862 | -13 | -0.2% | 858,100 |
2022/08/09 | 6,888 | 6,944 | 6,867 | 6,875 | +6 | +0.1% | 1,091,700 |
2022/08/08 | 6,810 | 6,882 | 6,780 | 6,869 | +114 | +1.7% | 1,360,300 |
2022/08/05 | 6,746 | 6,764 | 6,714 | 6,755 | -19 | -0.3% | 997,600 |
2022/08/04 | 6,751 | 6,775 | 6,670 | 6,774 | +23 | +0.3% | 1,439,100 |
2022/08/03 | 6,760 | 6,793 | 6,725 | 6,751 | -19 | -0.3% | 1,143,900 |
2022/08/02 | 6,846 | 6,920 | 6,770 | 6,770 | -88 | -1.3% | 1,837,800 |
2022/08/01 | 6,729 | 6,858 | 6,703 | 6,858 | +54 | +0.8% | 2,283,600 |
2022/07/29 | 6,950 | 6,950 | 6,781 | 6,804 | -118 | -1.7% | 2,212,100 |
2022/07/28 | 6,980 | 6,999 | 6,868 | 6,922 | -93 | -1.3% | 2,345,300 |
2022/07/27 | 6,990 | 7,040 | 6,973 | 7,015 | +47 | +0.7% | 1,954,600 |
2022/07/26 | 6,912 | 6,973 | 6,909 | 6,968 | +32 | +0.5% | 1,518,100 |
2022/07/25 | 6,860 | 6,940 | 6,830 | 6,936 | +49 | +0.7% | 1,931,100 |
2022/07/22 | 6,950 | 6,980 | 6,877 | 6,887 | -137 | -2% | 3,932,300 |
2022/07/21 | 6,800 | 7,033 | 6,786 | 7,024 | -516 | -6.8% | 9,363,000 |
2022/07/20 | 7,460 | 7,574 | 7,328 | 7,540 | +167 | +2.3% | 2,765,000 |
2022/07/19 | 7,495 | 7,503 | 7,350 | 7,373 | -84 | -1.1% | 2,454,900 |
2022/07/15 | 7,300 | 7,487 | 7,274 | 7,457 | +255 | +3.5% | 2,802,700 |
2022/07/14 | 7,132 | 7,212 | 7,127 | 7,202 | +59 | +0.8% | 1,233,800 |
2022/07/13 | 7,149 | 7,176 | 7,080 | 7,143 | -43 | -0.6% | 1,121,100 |
2022/07/12 | 7,216 | 7,264 | 7,145 | 7,186 | -29 | -0.4% | 1,191,200 |
2022/07/11 | 7,151 | 7,258 | 7,141 | 7,215 | +152 | +2.2% | 1,265,500 |
2022/07/08 | 7,030 | 7,130 | 6,966 | 7,063 | +53 | +0.8% | 2,051,300 |
2022/07/07 | 6,947 | 7,010 | 6,871 | 7,010 | +157 | +2.3% | 1,609,000 |
2022/07/06 | 6,889 | 6,928 | 6,790 | 6,853 | -131 | -1.9% | 1,680,400 |
2022/07/05 | 6,940 | 7,019 | 6,918 | 6,984 | +147 | +2.2% | 1,333,600 |
2022/07/04 | 6,741 | 6,915 | 6,719 | 6,837 | +103 | +1.5% | 1,151,300 |
2022/07/01 | 6,900 | 6,952 | 6,710 | 6,734 | -121 | -1.8% | 1,235,500 |
2022/06/30 | 6,801 | 6,900 | 6,777 | 6,855 | +15 | +0.2% | 1,307,100 |
2022/06/29 | 6,846 | 6,894 | 6,820 | 6,840 | -18 | -0.3% | 1,147,900 |
2022/06/28 | 6,755 | 6,871 | 6,708 | 6,858 | +100 | +1.5% | 1,141,200 |
2022/06/27 | 6,707 | 6,774 | 6,648 | 6,758 | +31 | +0.5% | 1,179,000 |
2022/06/24 | 6,508 | 6,727 | 6,481 | 6,727 | +319 | +5% | 2,370,900 |
2022/06/23 | 6,186 | 6,510 | 6,105 | 6,408 | -378 | -5.6% | 5,495,400 |
2022/06/22 | 6,798 | 6,870 | 6,742 | 6,786 | +86 | +1.3% | 1,597,900 |
2022/06/21 | 6,650 | 6,738 | 6,578 | 6,700 | +128 | +1.9% | 1,272,400 |
2022/06/20 | 6,590 | 6,616 | 6,486 | 6,572 | +45 | +0.7% | 1,098,800 |
2022/06/17 | 6,491 | 6,580 | 6,464 | 6,527 | -113 | -1.7% | 1,474,900 |
2022/06/16 | 6,693 | 6,777 | 6,605 | 6,640 | +147 | +2.3% | 1,689,500 |
2022/06/15 | 6,670 | 6,683 | 6,476 | 6,493 | -241 | -3.6% | 1,666,300 |
551~
600
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 210,100円 | +5.7% | +3.9% | 2.73% | 10.45倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 899,400円 | +14.4% | +120.8% | 1.33% | 20.18倍 | 1.85倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,900円 | +12.2% | +180.3% | 4.72% | 56.17倍 | 1.84倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 468,000円 | +1.7% | -2.9% | 3.42% | 30.70倍 | 1.61倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,700円 | +11.3% | -5.4% | 2.30% | 19.45倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム